Catalent, a prominent contract development and manufacturing organization (CDMO), has announced the divestment of its Somerset, New Jersey, oral solids development and small-scale manufacturing facility to Ardena, a Belgian CDMO. This transaction marks Ardena's entry into the U.S. market and
The market for gene therapies is predicted to surge from $9 billion in 2023 to $23.9 billion in 2028, according to MarketsandMarkets. With such rapid growth, it has become increasingly evident that having an effective analytical testing strategy is crucial for the successful development and
Eli Lilly is making a bold move to shape the future of pharmaceutical manufacturing with its $4.5 billion investment in the Lilly Medicine Foundry. This new facility, set to open in late 2027 in Lebanon, Indiana's LEAP Research and Innovation District, is poised to redefine how the industry
Wilson County, located in Eastern North Carolina, has recently become a hotspot for significant economic development, largely driven by substantial investments from pharmaceutical giants. Within the past eight days, the region has received promises of major funding, hinting at a promising future
Afton Scientific is making headlines with its substantial investment of over $200 million to expand its biopharmaceutical manufacturing facility in Albemarle County, Virginia. This significant expansion not only highlights the company's commitment to growth but also underscores the robust
The launch of Richter BioLogics' state-of-the-art biopharmaceutical Current Good Manufacturing Practice (cGMP) facility in Bovenau, Germany marks a significant milestone for the company and the industry at large. Positioned as a forefront leader in advanced biopharmaceutical production, the
